Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Eli Lilly and Company

Eli Lilly and Company

LLY · NYSE
LLY · NYSE

Next Dividends: 13 Nov 2026

1417.00
USD42.703.11%

Latest News

    CNBC

    Eli Lilly and J&J bounce on new data, as software stocks give up last week's gains

      SeekingAlpha

      4 stocks to watch on Monday: LLY, NVO, APO, TTE

        @MarketRebels
        MarketRebels

        Today's session starting off with a bounce #HeatMap 🟢 $MSFT $AAPL $NVDA $C $LLY $TSLA $BA $NEM $AMD https://t.co/p9sbQEQMFn

          @Investingcom
          Investingcom

          *ELI LILLY BLOWS PAST QUARTERLY ESTIMATES, POSTS STRONG OUTLOOK AS WEIGHT-LOSS DRUG SALES SOAR $LLY https://t.co/PR6TWpFi92

            SeekingAlpha

            4 stocks to watch on Tuesday: JPM, LLY, USB, PANW

              SeekingAlpha

              4 stocks to watch on Tuesday: META, LLY, BA, TAK

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              1409.01USD
              1437.74USD

              52 Week Range

              809.63USD
              1437.74USD

              Market Cap

              1.15TUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NYSE

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US5324571083

              CUSIP

              532457108

              Sector

              Healthcare

              Industry

              Drug Manufacturers - General

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              43.25

              PEG Ratio

              1.23

              Book Value

              29.66

              Dividend Share

              0

              Dividend Yield

              0.00%

              Earnings Share

              31.76

              Wall Street Target Price

              1,336.61

              EPS Estimate Current Year

              33.16

              EPS Estimate Next Year

              47.46

              EPS Estimate Current Quarter

              6.5845

              EPS Estimate Next Quarter

              9.4796

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              79,666,003,968

              Gross Profit TTM

              66,440,998,912

              EBITDA

              41,706,999,808

              Profit Margin

              33.53%

              Return On Assets TTM

              20.36%

              Return On Equity TTM

              102.29%

              Revenue Per Share TTM

              89.022

              Qtly Revenue Growth YOY

              47.70%

              Diluted Eps TTM

              31.76

              Qtly Earnings Growth YOY

              26.20%

              Valuation

              Trailing PE

              43.25

              Forward PE

              26

              Price Sales TTM

              15.3765

              Price Book MRQ

              33.8952

              Enterprise Value Revenue

              14

              Enterprise Value EBITDA

              28

              Peers analysis

              • AstraZeneca PLC
                AZNAstraZeneca PLC

                186.35

                6.89%
              • Merck & Company Inc
                MRKMerck & Company Inc

                149.59

                2.31%
              • Roche Holding AG
                RHHBFRoche Holding AG

                500.01

                2.04%
              • AbbVie Inc
                ABBVAbbVie Inc

                294.53

                1.56%
              • Amgen Inc
                AMGNAmgen Inc

                466.40

                1.25%
              • Roche Holding Ltd ADR
                RHHBYRoche Holding Ltd ADR

                61.30

                0.87%
              • Roche Holding AG Participation
                RHHVFRoche Holding AG Participation

                490.00

                0.54%
              • Novartis AG ADR
                NVSNovartis AG ADR

                161.11

                0.07%
              • Novartis AG
                NVSEFNovartis AG

                160.35

                0.00%
              • Johnson & Johnson
                JNJJohnson & Johnson

                273.70

                -0.54%

              FAQs

              What is Eli Lilly and Company stock price today?

              What is Eli Lilly and Company stock ticker?

              Is LLY stock price going up?

              What is the analyst recommendation for LLY?

              What is LLY market cap?

              Does LLY release financial reports?

              When is LLY next earnings date?

              What were LLY Earnings for the last quarter?

              What was LLY Revenue for the last quarter?

              What was LLY Net Income for the last quarter?

              Does LLY pay dividends?

              How many employees does LLY have?

              What is LLY EBITDA?

              How to buy LLY stocks?

              Should I invest in LLY stock?